Variant report

Variant	rs2514256
Chromosome Location	chr11:67171736-67171737
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr11:67171600-67171750	MCF-7	breast:	n/a	n/a
2	POLR2A	chr11:67171032-67171853	GM18505	blood:	n/a	n/a
3	MTA3	chr11:67171004-67173083	GM12878	blood:	n/a	n/a
4	POLR2A	chr11:67171081-67172007	GM12878	blood:	n/a	n/a
5	MTA3	chr11:67171144-67171751	GM12878	blood:	n/a	n/a
6	RUNX3	chr11:67171064-67171991	GM12878	blood:	n/a	n/a
7	SPI1	chr11:67171004-67171799	GM12878	blood:	n/a	chr11:67171388-67171401 chr11:67171395-67171404 chr11:67171323-67171330 chr11:67171389-67171402
8	POLR2A	chr11:67170866-67172517	GM12878	blood:	n/a	n/a
9	POLR2A	chr11:67170888-67172752	GM12892	blood:	n/a	n/a
10	STAT5A	chr11:67171119-67172789	GM12878	blood:	n/a	chr11:67171305-67171313 chr11:67172120-67172132 chr11:67171831-67171843
11	ELF1	chr11:67171019-67171897	GM12878	blood:	n/a	chr11:67171188-67171200 chr11:67171389-67171400
12	CHD1	chr11:67171221-67171741	GM12878	blood:	n/a	n/a
13	POLR2A	chr11:67171090-67171880	GM12878	blood:	n/a	n/a
14	EBF1	chr11:67171079-67171832	GM12878	blood:	n/a	n/a
15	POLR2A	chr11:67171026-67171834	GM12892	blood:	n/a	n/a
16	POLR2A	chr11:67171007-67171866	GM12892	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr11:67166766..67171737-chr11:67231413..67236466,7	K562	blood:
2	chr11:67167204..67172690-chr11:67247088..67251861,6	K562	blood:
3	chr11:67169616..67172754-chr11:67249059..67251001,3	MCF-7	breast:
4	chr11:67141172..67143536-chr11:67171363..67173683,2	K562	blood:
5	chr11:67171679..67173695-chr11:67249098..67251684,2	MCF-7	breast:

Variant related genes	Relation type
PPP1CA	TF binding region
TBC1D10C	TF binding region
ENSG00000110711	Chromatin interaction
ENSG00000175505	Chromatin interaction
ENSG00000172663	Chromatin interaction

Extended variants
information (count: 69 )
Associated
traits (count: 1 )

rSNPs within LD-proxies of this variant (count:48)

rs_ID	r²[population]
rs10896167	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.93[LWK][hapmap];0.95[MEX][hapmap];0.90[MKK][hapmap];0.82[TSI][hapmap];0.85[YRI][hapmap];0.86[ASN][1000 genomes]
rs10896168	0.84[AFR][1000 genomes];0.84[ASN][1000 genomes]
rs10896169	0.84[AFR][1000 genomes];0.82[ASN][1000 genomes]
rs10896172	0.82[TSI][hapmap]
rs1115051	0.85[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs11227756	0.85[ASW][hapmap];0.92[CHB][hapmap];0.97[CHD][hapmap];0.85[JPT][hapmap];0.86[LWK][hapmap];0.95[MEX][hapmap];0.81[MKK][hapmap];0.82[TSI][hapmap]
rs11227788	0.96[AFR][1000 genomes];0.99[AMR][1000 genomes];0.92[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs11601700	0.84[ASN][1000 genomes]
rs12276833	0.82[AFR][1000 genomes];0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs12288107	1.00[ASW][hapmap];0.80[CEU][hapmap];0.81[CHB][hapmap];0.85[CHD][hapmap];1.00[GIH][hapmap];0.86[JPT][hapmap];0.90[LWK][hapmap];0.95[MEX][hapmap];1.00[MKK][hapmap];0.92[TSI][hapmap];0.92[YRI][hapmap];0.92[AFR][1000 genomes];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs12290164	1.00[ASW][hapmap];0.80[CEU][hapmap];0.81[CHB][hapmap];0.85[CHD][hapmap];1.00[GIH][hapmap];0.93[JPT][hapmap];0.90[LWK][hapmap];0.95[MEX][hapmap];1.00[MKK][hapmap];0.92[TSI][hapmap];0.92[YRI][hapmap];0.88[AFR][1000 genomes];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs12788752	0.92[ASW][hapmap];0.85[CHB][hapmap];0.97[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.86[LWK][hapmap];0.91[MEX][hapmap];0.96[MKK][hapmap];0.93[YRI][hapmap];0.83[AFR][1000 genomes];0.87[ASN][1000 genomes]
rs1540135	0.84[AFR][1000 genomes];0.83[ASN][1000 genomes]
rs1558256	1.00[ASW][hapmap];0.80[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];0.93[JPT][hapmap];1.00[LWK][hapmap];0.95[MEX][hapmap];0.88[MKK][hapmap];0.92[TSI][hapmap];0.93[YRI][hapmap];0.96[AFR][1000 genomes];0.99[AMR][1000 genomes];0.92[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs1558257	0.82[TSI][hapmap]
rs1626067	0.86[LWK][hapmap];0.92[YRI][hapmap]
rs1638566	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.96[LWK][hapmap];0.95[MEX][hapmap];0.93[MKK][hapmap];0.82[TSI][hapmap];0.93[YRI][hapmap];0.87[AFR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs1638567	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.96[LWK][hapmap];0.95[MEX][hapmap];0.93[MKK][hapmap];0.82[TSI][hapmap];0.93[YRI][hapmap];0.84[AFR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs1638571	0.92[ASW][hapmap];0.88[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];0.95[MEX][hapmap];0.82[TSI][hapmap];0.86[YRI][hapmap];0.91[AFR][1000 genomes];0.88[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs1638574	0.83[AFR][1000 genomes];0.92[ASN][1000 genomes]
rs1638586	1.00[ASW][hapmap];1.00[GIH][hapmap];0.90[LWK][hapmap];0.91[MEX][hapmap];1.00[MKK][hapmap];0.92[TSI][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes];0.95[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs1790733	1.00[ASW][hapmap];0.80[CEU][hapmap];0.81[CHB][hapmap];0.85[CHD][hapmap];1.00[GIH][hapmap];0.86[JPT][hapmap];1.00[LWK][hapmap];0.95[MEX][hapmap];1.00[MKK][hapmap];0.92[TSI][hapmap];0.92[YRI][hapmap];0.95[AFR][1000 genomes];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs1790740	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.96[LWK][hapmap];0.95[MEX][hapmap];0.94[MKK][hapmap];0.82[TSI][hapmap];0.93[YRI][hapmap];0.87[AFR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs1790747	1.00[ASW][hapmap];0.80[CEU][hapmap];0.81[CHD][hapmap];1.00[GIH][hapmap];0.86[JPT][hapmap];0.86[LWK][hapmap];0.95[MEX][hapmap];0.96[MKK][hapmap];0.92[TSI][hapmap];0.92[YRI][hapmap];0.87[AFR][1000 genomes];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs1790748	0.87[AFR][1000 genomes];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs2066496	1.00[CEU][hapmap];0.85[CHB][hapmap];0.87[CHD][hapmap];1.00[GIH][hapmap];0.92[JPT][hapmap];0.91[TSI][hapmap];0.87[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs2071007	0.85[ASW][hapmap];0.92[CHB][hapmap];0.97[CHD][hapmap];0.89[LWK][hapmap];0.95[MEX][hapmap];0.81[MKK][hapmap];0.82[TSI][hapmap];0.81[YRI][hapmap]
rs2256154	0.95[CHD][hapmap];0.93[JPT][hapmap]
rs2286620	1.00[CEU][hapmap];0.85[CHB][hapmap];0.87[CHD][hapmap];1.00[GIH][hapmap];0.84[JPT][hapmap];0.91[TSI][hapmap];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs2429460	0.84[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs2429462	0.84[AFR][1000 genomes];0.89[ASN][1000 genomes]
rs2514258	0.84[AFR][1000 genomes];0.94[ASN][1000 genomes]
rs34596169	0.92[AFR][1000 genomes];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs3758943	0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[JPT][hapmap];0.93[YRI][hapmap]
rs3781941	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.86[LWK][hapmap];0.95[MEX][hapmap];0.96[MKK][hapmap];0.82[TSI][hapmap];0.93[YRI][hapmap];0.83[AFR][1000 genomes];0.82[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs3781942	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.93[LWK][hapmap];0.95[MEX][hapmap];0.96[MKK][hapmap];0.82[TSI][hapmap];0.93[YRI][hapmap];0.87[AFR][1000 genomes];0.82[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs3781943	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];0.97[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.96[LWK][hapmap];0.95[MEX][hapmap];0.93[MKK][hapmap];0.85[YRI][hapmap];0.82[AFR][1000 genomes];0.86[ASN][1000 genomes]
rs3909168	0.87[AFR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs3927807	0.92[ASW][hapmap];0.88[CEU][hapmap];0.85[CHB][hapmap];0.85[JPT][hapmap];0.85[LWK][hapmap]
rs4024520	0.87[ASN][1000 genomes]
rs4255546	0.88[CEU][hapmap];0.92[CHB][hapmap];0.97[CHD][hapmap];0.83[GIH][hapmap];0.92[JPT][hapmap];0.95[MEX][hapmap];0.82[TSI][hapmap];0.83[ASN][1000 genomes]
rs4930192	0.88[CEU][hapmap];0.86[CHD][hapmap];0.83[GIH][hapmap];0.92[JPT][hapmap]
rs4930197	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.86[LWK][hapmap];0.95[MEX][hapmap];0.96[MKK][hapmap];0.82[TSI][hapmap];0.93[YRI][hapmap];0.81[AFR][1000 genomes];0.80[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4930418	0.88[CEU][hapmap];0.87[CHD][hapmap];0.83[GIH][hapmap];0.92[JPT][hapmap]
rs7106352	0.84[AFR][1000 genomes];0.92[ASN][1000 genomes]
rs7480390	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.93[YRI][hapmap];0.90[AFR][1000 genomes];0.99[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs872109	0.95[AFR][1000 genomes];0.96[AMR][1000 genomes];0.88[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs872110	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];0.93[JPT][hapmap];0.90[LWK][hapmap];0.95[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.99[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:21 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv531397	chr11:66653381-67465721	Active TSS Enhancers Strong transcription Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	271 gene(s)	inside rSNPs	diseases
2	nsv897796	chr11:67021518-67186000	Weak transcription Strong transcription Active TSS Flanking Active TSS Enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
3	nsv897797	chr11:67023040-67293234	Flanking Active TSS Strong transcription Enhancers Active TSS Weak transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	206 gene(s)	inside rSNPs	diseases
4	nsv1043037	chr11:67027193-67357425	Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Genic enhancers Active TSS ZNF genes & repeats Weak transcription Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	213 gene(s)	inside rSNPs	diseases
5	nsv897801	chr11:67033076-67432479	Bivalent Enhancer Enhancers Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	236 gene(s)	inside rSNPs	diseases
6	nsv1047890	chr11:67058231-67184436	Flanking Active TSS Enhancers Strong transcription Genic enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	88 gene(s)	inside rSNPs	diseases
7	nsv1048230	chr11:67058231-67252397	Active TSS Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	146 gene(s)	inside rSNPs	diseases
8	nsv897804	chr11:67090571-67224278	Flanking Active TSS Enhancers Weak transcription Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
9	nsv1039205	chr11:67135246-67252397	Enhancers Strong transcription Active TSS Flanking Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	122 gene(s)	inside rSNPs	diseases
10	esv1818769	chr11:67138811-67300457	Flanking Active TSS Active TSS Genic enhancers Weak transcription Enhancers Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	167 gene(s)	inside rSNPs	diseases
11	esv1798859	chr11:67139954-67272983	Active TSS Weak transcription Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	154 gene(s)	inside rSNPs	diseases
12	nsv897805	chr11:67155210-67283891	ZNF genes & repeats Flanking Active TSS Genic enhancers Enhancers Weak transcription Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	148 gene(s)	inside rSNPs	diseases
13	nsv897806	chr11:67155210-67294308	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Genic enhancers Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	148 gene(s)	inside rSNPs	diseases
14	nsv897807	chr11:67155210-67414492	Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	176 gene(s)	inside rSNPs	diseases
15	nsv897808	chr11:67155210-67419855	Flanking Active TSS Strong transcription Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	176 gene(s)	inside rSNPs	diseases
16	nsv897809	chr11:67156875-67276235	Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	148 gene(s)	inside rSNPs	diseases
17	nsv516453	chr11:67164495-67186000	Genic enhancers Active TSS Flanking Active TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
18	nsv555254	chr11:67164495-67288594	Weak transcription Flanking Active TSS Active TSS Genic enhancers Enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	146 gene(s)	inside rSNPs	diseases
19	nsv534229	chr11:67164667-67411909	Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	175 gene(s)	inside rSNPs	diseases
20	nsv897810	chr11:67166310-67196237	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	54 gene(s)	inside rSNPs	diseases
21	nsv897811	chr11:67166984-67218909	Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	70 gene(s)	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs2514256	RPS6KB2	cis	lymphoblastoid	seeQTL

Chromatin state (count:92 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:67169600-67172600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
2	chr11:67169600-67172800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr11:67169800-67172200	Weak transcription	HSMM	muscle
4	chr11:67169800-67172400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr11:67169800-67172400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
6	chr11:67169800-67172600	Enhancers	Fetal Muscle Trunk	muscle
7	chr11:67169800-67174400	Weak transcription	Brain Angular Gyrus	brain
8	chr11:67169800-67174600	Weak transcription	HSMMtube	muscle
9	chr11:67169800-67175000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
10	chr11:67169800-67175000	Weak transcription	Fetal Brain Male	brain
11	chr11:67169800-67176800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
12	chr11:67169800-67177800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr11:67169800-67178000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr11:67170000-67171800	Enhancers	Skeletal Muscle Female	skeletal muscle
15	chr11:67170000-67172000	Weak transcription	Muscle Satellite Cultured Cells	--
16	chr11:67170000-67172200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr11:67170000-67172200	Weak transcription	Hela-S3	cervix
18	chr11:67170000-67172200	Weak transcription	NH-A	brain
19	chr11:67170000-67172200	Weak transcription	Osteobl	bone
20	chr11:67170000-67174000	Weak transcription	Brain Inferior Temporal Lobe	brain
21	chr11:67170000-67174400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
22	chr11:67170000-67177200	Weak transcription	HUES64 Cell Line	embryonic stem cell
23	chr11:67170000-67177200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr11:67170000-67182800	Weak transcription	Right Atrium	heart
25	chr11:67170200-67171800	Weak transcription	HMEC	breast
26	chr11:67170200-67173600	Weak transcription	Brain Cingulate Gyrus	brain
27	chr11:67170200-67173600	Weak transcription	Brain Substantia Nigra	brain
28	chr11:67170200-67174400	Weak transcription	Right Ventricle	heart
29	chr11:67170200-67175800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr11:67170200-67176600	Weak transcription	H1 Cell Line	embryonic stem cell
31	chr11:67170400-67172000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
32	chr11:67170600-67172400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
33	chr11:67170600-67172800	Flanking Active TSS	HepG2	liver
34	chr11:67170800-67171800	Weak transcription	Brain Anterior Caudate	brain
35	chr11:67170800-67172200	Active TSS	Colonic Mucosa	Colon
36	chr11:67170800-67172400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
37	chr11:67170800-67172400	Active TSS	Thymus	Thymus
38	chr11:67170800-67172800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
39	chr11:67170800-67172800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr11:67170800-67173000	Flanking Active TSS	Primary hematopoietic stem cells	blood
41	chr11:67170800-67173200	Flanking Active TSS	Primary B cells from cord blood	blood
42	chr11:67170800-67174000	Weak transcription	Brain Hippocampus Middle	brain
43	chr11:67171000-67171800	Active TSS	Rectal Mucosa Donor 29	rectum
44	chr11:67171000-67172000	Active TSS	GM12878-XiMat	blood
45	chr11:67171000-67172200	Active TSS	Duodenum Mucosa	Duodenum
46	chr11:67171000-67172400	Active TSS	Primary T killer naive cells fromperipheralblood	blood
47	chr11:67171000-67172600	Active TSS	Primary T cells from cord blood	blood
48	chr11:67171000-67173400	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
49	chr11:67171000-67176800	Weak transcription	Lung	lung
50	chr11:67171000-67177200	Weak transcription	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links